Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis

Phase 2 Completed 22 enrolled The University of Texas Health Science Center, Houston Pacira Pharmaceuticals, Inc · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and efficacy of FX006 in bursal injections and to assess the patient's impression to change in their chronic pain, following treatment.

Timeline

Start: 2020-08-12
Primary completion: 2022-12-14
Completion: 2022-12-14

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tafamidis	Unknown	5 ml	Other
Background	Ropivacaine	Other / unclassified	3 ml	—

Indications

No indication recorded.